pravastatin has been researched along with Complications of Diabetes Mellitus in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (7.69) | 18.7374 |
| 1990's | 8 (30.77) | 18.2507 |
| 2000's | 10 (38.46) | 29.6817 |
| 2010's | 6 (23.08) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, SA; Kim, JH; Lee, JM; Lee, MR; Lee, SS; Shin, JA; Yoon, KH; You, SJ | 1 |
| Hu, MY; Jia, LL; Li, F; Liu, C; Liu, L; Liu, XD; Xu, D; Yang, Y; Zhang, M; Zhong, ZY | 1 |
| Ford, I; McCowan, C; Murray, H; Packard, CJ | 1 |
| Elsais, A; Kerty, E; Lund, C | 1 |
| Aihara, K; Amano, A; Daida, H; Kajimoto, K; Kasai, T; Kojima, T; Kubota, N; Kurata, T; Miyauchi, K; Tamura, H; Yokoyama, K | 1 |
| Blauw, GJ; Bollen, EL; de Craen, AJ; de Roos, A; Jukema, JW; Middelkoop, HA; van Buchem, MA; van der Grond, J; van Elderen, SG; Westendorp, RG | 1 |
| Arca, M; Budal, S; Degli Esposti, E; Degli Esposti, L; Sangiorgi, D; Vigna, GB | 1 |
| Lee, SJ; Sacks, FM | 1 |
| Diener, HC | 1 |
| Gandhi, SK; Harley, CR; Heien, H; McDonough, K; Nelson, SP | 1 |
| Cressman, MD; Ganda, OP; Lodewick, PA; McGovern, ME; Phillipson, B; Raskin, P; Rosenstock, J; Schwartz, S; Weiner, B; Willard, D | 1 |
| Durrington, P | 1 |
| Barrett e Pesquisadores, AC | 1 |
| Adkins, JC; Faulds, D | 1 |
| Braunwald, E; Cole, TG; Davis, BR; Goldberg, RB; Howard, BV; Howard, WJ; Mellies, MJ; Moyé, LA; Pfeffer, MA; Sacks, FM | 1 |
| Chua, TP; Fox, KM; Saia, F | 1 |
| Jackson, G | 1 |
| Ishikawa, T; Ito, H; Nakamura, H; Ohashi, Y; Orimo, H; Ouchi, Y; Saito, Y | 1 |
| Steiner, G | 1 |
| Barbaki, P; Dagre, AG; Lekakis, JP; Papaioannou, TG; Papamichael, CM; Stamatelopoulos, KS; Stamatelopoulos, SF | 1 |
| Braunwald, E; Craven, T; Furberg, CD; Keech, A; Pfeffer, MA; Sacks, FM; Shepherd, J; Tonkin, AM | 1 |
| Toyota, T | 1 |
| Arbeeny, CM; Bergquist, KE | 1 |
| Baba, S; Inui, A; Iwai, M; Iwatani, I; Kasama, T; Kazumi, T; Otsuki, M; Uenoyama, R; Yokono, K; Yoshino, G | 1 |
| Baba, S; Inui, A; Iwai, M; Iwatani, I; Kasama, T; Kazumi, T; Otsuki, M; Yoshino, G | 1 |
3 review(s) available for pravastatin and Complications of Diabetes Mellitus
| Article | Year |
|---|---|
Statins and fibrates in the management of diabetic dyslipidemia.
Topics: Diabetes Complications; Diabetes Mellitus; Fenofibrate; Humans; Hyperlipidemias; Hypolipidemic Agents; Lovastatin; Pravastatin; Simvastatin | 1997 |
Micronised fenofibrate: a review of its pharmacodynamic properties and clinical efficacy in the management of dyslipidaemia.
Topics: Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Clinical Trials as Topic; Controlled Clinical Trials as Topic; Diabetes Complications; Dose-Response Relationship, Drug; Drug Delivery Systems; Drug Tolerance; Fenofibrate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Lipoproteins, LDL; Pravastatin; Simvastatin | 1997 |
The use of fibrates and of statins in preventing atherosclerosis in diabetes.
Topics: Anticholesteremic Agents; Arteriosclerosis; Clinical Trials as Topic; Clofibrate; Diabetes Complications; Diabetes Mellitus; Humans; Hypolipidemic Agents; Pravastatin; Simvastatin | 2001 |
8 trial(s) available for pravastatin and Complications of Diabetes Mellitus
| Article | Year |
|---|---|
Effects of pravastatin on serum adiponectin levels in female patients with type 2 diabetes mellitus.
Topics: Adiponectin; Adult; Aged; Body Mass Index; Diabetes Complications; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lipids; Middle Aged; Pravastatin | 2013 |
Progression of brain atrophy and cognitive decline in diabetes mellitus: a 3-year follow-up.
Topics: Aged; Aged, 80 and over; Atrophy; Brain; Cognition Disorders; Diabetes Complications; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperglycemia; Hypoglycemic Agents; Insulin; Linear Models; Magnetic Resonance Imaging; Male; Neuropsychological Tests; Pravastatin | 2010 |
Effect of pravastatin on intermediate-density and low-density lipoproteins containing apolipoprotein CIII in patients with diabetes mellitus.
Topics: Aged; Anticholesteremic Agents; Apolipoprotein C-III; Apolipoproteins C; Coronary Disease; Diabetes Complications; Diabetes Mellitus; Double-Blind Method; Female; Follow-Up Studies; Humans; Hyperlipidemias; Lipoproteins; Lipoproteins, IDL; Lipoproteins, LDL; Male; Middle Aged; Pravastatin; Time Factors | 2003 |
Efficacy and safety of pravastatin in the treatment of patients with type I or type II diabetes mellitus and hypercholesterolemia.
Topics: Adult; Aged; Anticholesteremic Agents; Diabetes Complications; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Humans; Hypercholesterolemia; Lipids; Male; Middle Aged; Postmenopause; Pravastatin; Treatment Outcome | 1995 |
[Pravastatin multicenter clinical trial in patients with hypercholesterolemia and multiple risk factors].
Topics: Adolescent; Adult; Aged; Analysis of Variance; Anticholesteremic Agents; Diabetes Complications; Female; Humans; Hypercholesterolemia; Hypertension; Male; Menopause; Middle Aged; Obesity; Pravastatin; Risk Factors; Sex Factors; Smoking | 1997 |
Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investigators.
Topics: Adult; Aged; Anticholesteremic Agents; Cholesterol; Diabetes Complications; Diabetes Mellitus; Female; Glucose Intolerance; Humans; Male; Middle Aged; Myocardial Infarction; Pravastatin; Risk | 1998 |
A comparison of low versus standard dose pravastatin therapy for the prevention of cardiovascular events in the elderly: the pravastatin anti-atherosclerosis trial in the elderly (PATE).
Topics: Aged; Aged, 80 and over; Anticholesteremic Agents; Arteriosclerosis; Cardiovascular Diseases; Cholesterol; Diabetes Complications; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Pravastatin; Prospective Studies; Risk Factors; Safety; Triglycerides | 2001 |
Coronary heart disease in patients with low LDL-cholesterol: benefit of pravastatin in diabetics and enhanced role for HDL-cholesterol and triglycerides as risk factors.
Topics: Adult; Aged; Australia; Canada; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Diabetes Complications; Diabetes Mellitus; Double-Blind Method; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; New Zealand; Pravastatin; Risk Factors; Treatment Outcome; Triglycerides; United States | 2002 |
15 other study(ies) available for pravastatin and Complications of Diabetes Mellitus
| Article | Year |
|---|---|
Co-administration of paroxetine and pravastatin causes deregulation of glucose homeostasis in diabetic rats via enhanced paroxetine exposure.
Topics: Animals; Anticholesteremic Agents; Antidepressive Agents, Second-Generation; Blood Glucose; Cell Line; Depression; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Drug Interactions; Hypercholesterolemia; Insulin; Male; Paroxetine; Pravastatin; Rats; Rats, Sprague-Dawley; Serotonin | 2014 |
Long-Term Safety and Efficacy of Lowering Low-Density Lipoprotein Cholesterol With Statin Therapy: 20-Year Follow-Up of West of Scotland Coronary Prevention Study.
Topics: Cardiovascular Diseases; Cause of Death; Cholesterol, LDL; Diabetes Complications; Diabetes Mellitus; Follow-Up Studies; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Mortality; Neoplasms; Pravastatin; Proportional Hazards Models; Randomized Controlled Trials as Topic; Scotland; Survival Analysis | 2016 |
Ptosis, diplopia and statins: an association?
Topics: Adult; Atorvastatin; Autoantibodies; Autoimmune Diseases of the Nervous System; Azetidines; Blepharoptosis; Diabetes Complications; Diagnostic Errors; Diplopia; Eyelid Diseases; Ezetimibe; Heptanoic Acids; Humans; Hypercholesterolemia; Male; Myasthenia Gravis; Myocardial Infarction; Pain; Pravastatin; Pyrroles; Receptors, Cholinergic; Recurrence; Strabismus | 2008 |
Long-term efficacy of pravastatin therapy in diabetic patients undergoing complete coronary revascularization.
Topics: Coronary Artery Disease; Diabetes Complications; Diabetes Mellitus; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Revascularization; Pravastatin; Risk Factors; Survival Rate; Treatment Outcome | 2010 |
[Achievement of therapeutic target in subjects on statin treatment in clinical practice. Results of the STAR (Statins Target Assessment in Real practice) study].
Topics: Aged; Algorithms; Azetidines; Biomarkers; Cardiovascular Diseases; Cerebrovascular Disorders; Cholesterol, LDL; Cohort Studies; Diabetes Complications; Diabetes Mellitus; Ezetimibe; Female; Fluorobenzenes; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Italy; Lovastatin; Male; Medication Adherence; Middle Aged; Pravastatin; Pyrimidines; Retrospective Studies; Risk Assessment; Risk Factors; Rosuvastatin Calcium; Simvastatin; Sulfonamides; Treatment Outcome | 2011 |
[Primary prevention of stroke. What helps--what does not help? The guidelines of the German Society of Neurology briefly summarized].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Aged; Alcohol Drinking; Anticholesteremic Agents; Anticoagulants; Antihypertensive Agents; Arrhythmias, Cardiac; Aspirin; Atenolol; Atrial Fibrillation; Carotid Artery, Internal; Carotid Stenosis; Chlorthalidone; Clinical Trials as Topic; Diabetes Complications; Diuretics; Doxazosin; Female; Fibrinolytic Agents; Hormone Replacement Therapy; Humans; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Life Style; Losartan; Male; Neurology; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Pravastatin; Primary Prevention; Risk Factors; Simvastatin; Smoking; Societies, Medical; Stroke | 2003 |
[Intensive LDL lowering to under 80 mg/dl: hypercholesteremia patients with stable coronary disease and diabetes profit especially significantly].
Topics: Anticholesteremic Agents; Atorvastatin; Cardiovascular Diseases; Cholesterol, LDL; Clinical Trials as Topic; Coronary Disease; Diabetes Complications; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Life Expectancy; Pravastatin; Pyrroles; Risk; Risk Factors; Time Factors | 2005 |
Lipid levels and low-density lipoprotein cholesterol goal attainment in diabetic patients: rosuvastatin compared with other statins in usual care.
Topics: Adult; Aged; Atorvastatin; Cardiovascular Diseases; Cholesterol, LDL; Cohort Studies; Diabetes Complications; Fatty Acids, Monounsaturated; Female; Fluorobenzenes; Fluvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Lovastatin; Male; Managed Care Programs; Middle Aged; Practice Guidelines as Topic; Pravastatin; Pyrimidines; Pyrroles; Retrospective Studies; Risk Factors; Rosuvastatin Calcium; Simvastatin; Sulfonamides; Treatment Outcome; United States | 2008 |
The management of hypercholesterolaemia in patients with coronary artery disease referred for coronary angiography.
Topics: Aged; Anticholesteremic Agents; Cholesterol; Cohort Studies; Coronary Angiography; Coronary Disease; Data Interpretation, Statistical; Diabetes Complications; Female; Follow-Up Studies; Humans; Hypercholesterolemia; Hypertension; Male; Middle Aged; Pravastatin; Risk Factors; Simvastatin; Smoking; Treatment Outcome | 1998 |
Diabetes, statins and cardiovascular disease.
Topics: Anticholesteremic Agents; Cardiovascular Diseases; Diabetes Complications; Diabetic Angiopathies; Humans; Hyperlipidemias; Pravastatin | 2001 |
Comparison of low-density lipoprotein cholesterol lowering by pravastatin to <100 mg/dl versus >100 mg/dl on brachial artery vasoreactivity in patients with severe hypercholesterolemia and previous atherosclerotic events or diabetes mellitus.
Topics: Adult; Aged; Anticholesteremic Agents; Arteriosclerosis; Brachial Artery; Cholesterol, LDL; Diabetes Complications; Diabetes Mellitus; Drug Administration Schedule; Endothelium, Vascular; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Pravastatin; Treatment Outcome; Vasodilation | 2002 |
[Diabetes mellitus and hyperlipidemia].
Topics: Arteriosclerosis; Diabetes Complications; Diabetes Mellitus; Humans; Hyperlipidemias; Lipid Metabolism; Lovastatin; Pravastatin | 1992 |
The effect of pravastatin on serum cholesterol levels in hypercholesterolemic diabetic rabbits.
Topics: Animals; Anticholesteremic Agents; Apolipoproteins; Body Weight; Cholesterol; Coconut Oil; Diabetes Complications; Diabetes Mellitus; Diet, Atherogenic; Disease Models, Animal; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lipoproteins; Male; Naphthalenes; Plant Oils; Pravastatin; Rabbits; Triglycerides | 1991 |
Probucol versus eptastatin in hypercholesterolaemic diabetics.
Topics: Cholesterol, HDL; Diabetes Complications; Female; Heptanoic Acids; Humans; Hypercholesterolemia; Male; Naphthalenes; Phenols; Pravastatin; Probucol | 1986 |
Effect of CS-514, an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on lipoprotein and apolipoprotein in plasma of hypercholesterolemic diabetics.
Topics: Apolipoproteins; Apolipoproteins B; Cholesterol, HDL; Cholesterol, LDL; Diabetes Complications; Diabetes Mellitus; Glycated Hemoglobin; Heptanoic Acids; Humans; Hypercholesterolemia; Lipoproteins; Naphthalenes; Pravastatin | 1986 |